TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
SMAD3 |
HCASMC (Human coronary artery smooth muscle cells) |
CellLine: A549 |
Permissive
|
Homo sapiens |
GSE115317
...
|
MA0513.1
...
|
SMAD3 |
MDA-MB-231 (breast adenocarcinoma) |
Treatment: Untreated |
Permissive
|
Homo sapiens |
GSE92443
...
|
MA0513.1
...
|
SMAD3 |
MDA-MB-231 (breast adenocarcinoma) |
Treatment: 2 ng/mLTGF beta, 1 hr |
Permissive
Robust
|
Homo sapiens |
GSE92443
...
|
MA0513.1
...
|
SMAD3 |
embryonic fibroblasts |
Treatment: + 1 ug/ml doxycycline Genotype: Smad3CA expression Source: day 3 of reprogramming |
Permissive
|
Mus musculus |
GSE85177
...
|
MA0513.1
...
|
SMAD3 |
embryonic fibroblasts |
Treatment: no Genotype: Smad3CA expression Source: day 3 of reprogramming |
Permissive
|
Mus musculus |
GSE85177
...
|
MA0513.1
...
|
SMAD3 |
striatum |
Strain: C57BL/6J Age: 4 months Genotype: wildtype Sex: male |
Permissive
|
Mus musculus |
GSE88775
...
|
MA0513.1
...
|
SMAD3 |
striatum |
Strain: C57BL/6J Age: 4 months Genotype: Q111/+ Sex: male |
Permissive
|
Mus musculus |
GSE88775
...
|
MA0513.1
...
|
SMAD3 |
PC3(bone mets prostate adenocarcinoma) |
Treatment: hypoxia (0.2% O2); |
Permissive
Robust
|
Homo sapiens |
GSE106305
...
|
MA0513.1
...
|
SMAD3 |
embryonic stem cell-drived neuroepithelial cells |
|
Permissive
|
Mus musculus |
GSE76557
...
|
MA0513.1
...
|
SMAD4 |
CD4+ T-cells |
IL6+TGFbR inhibitor |
Permissive
|
Mus musculus |
GSE101593
...
|
MA0513.1
...
|
Showing 10 records in page 3
from 5 pages